New trial data for the drug Donanemab [[don-AHN-eh-mab]] has shown it to slow the progression of memory and thinking problems by about a third.
Listen to SBS Indonesian every Monday, Wednesday, Friday, and Sunday at 3 pm.

A PET brain scan from a US Alzheimer's Institute (AAP).
New trial data for the drug Donanemab [[don-AHN-eh-mab]] has shown it to slow the progression of memory and thinking problems by about a third.
Listen to SBS Indonesian every Monday, Wednesday, Friday, and Sunday at 3 pm.